Diagnostic and therapeutic difficulties in pulmonary aspergillosis (PA) in paediatric cystic fibrosis (CF) patients

I. De Schutter, E. De Wachter, C. Ernst, A. Goossens, A. Malfroot (Brussels, Belgium)

Source: Annual Congress 2006 - Cystic fibrosis lung disease: infection, inflammation or both?
Session: Cystic fibrosis lung disease: infection, inflammation or both?
Session type: Thematic Poster Session
Number: 2800
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. De Schutter, E. De Wachter, C. Ernst, A. Goossens, A. Malfroot (Brussels, Belgium). Diagnostic and therapeutic difficulties in pulmonary aspergillosis (PA) in paediatric cystic fibrosis (CF) patients. Eur Respir J 2006; 28: Suppl. 50, 2800

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Macrolides in cystic fibrosis (CF); clinical experience
Source: Eur Respir J 2004; 24: Suppl. 48, 615s
Year: 2004

Omalizumab for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in children with cystic fibrosis (CF)
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014


High frequency chest wall oscillation (HFCWO) in the treatment of acute pulmonary exacerbation in adult cystic fibrosis (CF) patients
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013


Hyperinflation in adult cystic fibrosis (CF) patients: Clinical and functional correlates
Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies
Year: 2010

The oral AntibioticS approprIateness score (OASIS) – A novel scoring system to assess antibiotic route in pulmonary exacerbations of cystic fibrosis (CF)
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013


Therapeutic options and management of pulmonary fibrosis: old and new
Source: Annual Congress 2005 - PG15 - Therapeutic options for interstitial lung diseases in 2005
Year: 2005

Indicators of pulmonary exacerbation in adults with cystic fibrosis (CF)
Source: Annual Congress 2011 - Cystic fibrosis: New aspects of diagnosis, inflammation and detecting exacerbation
Year: 2011



Scedosporium species (Sspp) in patients with cystic fibrosis (CF): Implications for clinical practice
Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more
Year: 2010


Magnetic-resonance-imaging (MRI) for assessment of regional therapy response in patients with cystic fibrosis (CF)
Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Year: 2009


Clinical experience with Nintedanib for treatment of idiopathic pulmonary fibrosis (IPF) in Spain.
Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside
Year: 2017

Breathing pattern during rest and exercise in patients with cystic fibrosis (CF), pulmonary fibrosis (PF) and COPD before lung transplantation
Source: Eur Respir J 2005; 26: Suppl. 49, 685s
Year: 2005

Respiratory infections in patients with idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: concepts and mechanisms
Year: 2009

Microbial findings in children with cystic fibrosis. The value of bronchoscopy
Source: Annual Congress 2005 - Paediatric bronchology - a broad field
Year: 2005


Non-cystic fibrosis bronchiectasis in children
Source: Annual Congress 2005 - MP11 - Non-cystic fibrosis bronchiectasis in children
Year: 2005

Monitoring small airways disease (SAD) in cystic fibrosis (CF)
Source: Annual Congress 2011 - Monitoring with lung function tests in airway diseases
Year: 2011


Pulmonary tuberculosis (TB) as a complication of idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis
Year: 2009


Changes in total IgE levels predict pulmonary outcome in cystic fibrosis related allergic bronchopulmonary aspergillosis
Source: International Congress 2016 – Cystic fibrosis: various aspects
Year: 2016

Are there differences in response to pulmonary rehabilitation (PR) in idiopathic pulmonary fibrosis (IPF) and COPD patients?
Source: International Congress 2017 – New insights into pulmonary rehabilitation in patients with chronic lung diseases
Year: 2017

Effect of recurrent growth of aspergillus on lung function in paediatric population with cystic fibrosis (CF)
Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge
Year: 2011